Stay updated on Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now identifies the release as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T15:01:53.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A notice about NIH websites transitioning terminology from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error message.
    Difference
    1%
    Check dated 2026-10-24T14:35:00.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:23:31.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error; its footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T14:27:44.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study page now loads a 403 Forbidden error, replacing the usual study content with a generic error page. This prevents access to the trial details and related information.
    Difference
    20%
    Check dated 2026-09-19T18:35:39.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Adds a 2018 U.S. NIH Grant/Contract funding line and updates the page revision from v3.6.5 to v3.6.6, reflecting administrative record updates.
    Difference
    0.1%
    Check dated 2026-08-29T18:58:28.000Z thumbnail image

Stay in the know with updates to Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lonca Tesirine + Ibrutinib in Lymphoma Clinical Trial page.